4 Stocks Underperforming Today In The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 58 points (-0.4%) at 15,461 as of Wednesday, Aug. 7, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 785 issues advancing vs. 2,161 declining with 94 unchanged.

The Health Services industry currently sits down 1.1% versus the S&P 500, which is down 0.4%. On the negative front, top decliners within the industry include Tenet Healthcare ( THC), down 3.4%, Mindray Medical International ( MR), down 1.8%, Catamaran ( CTRX), down 0.8%, Boston Scientific ( BSX), down 0.8% and Aetna ( AET), down 0.7%. Top gainers within the industry include Tornier N.V ( TRNX), up 20.0%, Varian Medical Systems ( VAR), up 0.8%, Agilent Technologies ( A), up 0.7% and Cigna ( CI), up 0.5%.

TheStreet would like to highlight 4 stocks pushing the industry lower today:

4. Steris Corporation ( STE) is one of the companies pushing the Health Services industry lower today. As of noon trading, Steris Corporation is down $1.89 (-4.2%) to $43.65 on heavy volume. Thus far, 331,066 shares of Steris Corporation exchanged hands as compared to its average daily volume of 276,300 shares. The stock has ranged in price between $43.02-$45.22 after having opened the day at $44.55 as compared to the previous trading day's close of $45.54.

STERIS Corporation develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. Steris Corporation has a market cap of $2.7 billion and is part of the health care sector. Shares are up 31.1% year to date as of the close of trading on Tuesday. Currently there is 1 analyst that rates Steris Corporation a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Steris Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, reasonable valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Steris Corporation Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, DaVita HealthCare Partners ( DVA) is down $3.18 (-2.7%) to $113.16 on heavy volume. Thus far, 1.3 million shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 794,900 shares. The stock has ranged in price between $112.43-$115.05 after having opened the day at $114.85 as compared to the previous trading day's close of $116.34.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $12.4 billion and is part of the health care sector. Shares are up 5.3% year to date as of the close of trading on Tuesday. Currently there are 8 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DaVita HealthCare Partners Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Intuitive Surgical ( ISRG) is down $2.92 (-0.7%) to $390.01 on light volume. Thus far, 172,232 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 587,100 shares. The stock has ranged in price between $386.20-$393.72 after having opened the day at $393.41 as compared to the previous trading day's close of $392.93.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $15.6 billion and is part of the health care sector. Shares are down 19.7% year to date as of the close of trading on Tuesday. Currently there are 8 analysts that rate Intuitive Surgical a buy, 2 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Express Scripts ( ESRX) is down $0.30 (-0.5%) to $65.97 on average volume. Thus far, 1.7 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.4 million shares. The stock has ranged in price between $65.62-$66.20 after having opened the day at $66.14 as compared to the previous trading day's close of $66.27.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $54.0 billion and is part of the health care sector. Shares are up 22.7% year to date as of the close of trading on Tuesday. Currently there are 13 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Express Scripts Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null